-
NUMBER OF INSIDER BUYING
(Last 12 Months)
3 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
5 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$5.05 M -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$4.46 M
Terns Pharmaceuticals, Inc. Insider Transactions
Terns Pharmaceuticals, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Yoon Seokho Bryan
COO and General Counsel |
Buy | 4,791 @ $4.44 | $21,272 | 91,940 | 05/31/2024 | 06/04/2024 | |
|
Vignola Mark J.
CFO |
Buy | 4,791 @ $4.44 | $21,272 | 91,940 | 05/31/2024 | 06/04/2024 | |
|
Vivo Opportunity, LLC
10 percent owner |
Sell | 103,870 @ $6.20 | $643,994 | 4,023,741 | 04/03/2024 | 04/03/2024 | |
|
Vivo Opportunity, LLC
10 percent owner |
Sell | 30,047 @ $6.20 | $186,291 | 1,945,015 | 04/03/2024 | 04/03/2024 | |
|
Vivo Opportunity, LLC
10 percent owner |
Sell | 4,149 @ $6.20 | $25,724 | 268,573 | 04/03/2024 | 04/03/2024 | |
|
Vivo Opportunity, LLC
10 percent owner |
Sell | 76,346 @ $6.65 | $507,701 | 4,127,611 | 04/02/2024 | 04/03/2024 | |
|
Vivo Opportunity, LLC
10 percent owner |
Sell | 3,050 @ $6.65 | $20,283 | 272,722 | 04/02/2024 | 04/03/2024 | |
|
Vivo Opportunity, LLC
10 percent owner |
Sell | 22,084 @ $6.65 | $146,859 | 1,975,062 | 04/02/2024 | 04/03/2024 | |
|
Vivo Opportunity, LLC
10 percent owner |
Sell | 39,411 @ $6.99 | $275,483 | 1,997,146 | 04/01/2024 | 04/03/2024 | |
|
Vivo Opportunity, LLC
10 percent owner |
Sell | 5,451 @ $6.99 | $38,102 | 275,772 | 04/01/2024 | 04/03/2024 | |
|
Vivo Opportunity, LLC
10 percent owner |
Sell | 136,255 @ $6.99 | $952,422 | 4,203,957 | 04/01/2024 | 04/03/2024 | |
|
Yoon Seokho Bryan
COO and General Counsel |
Buy | 743 @ $3.78 | $2,809 | 18,399 | 11/30/2023 | 12/04/2023 | |
|
Vignola Mark J.
CFO |
Buy | 743 @ $3.78 | $2,809 | 18,399 | 11/30/2023 | 12/04/2023 | |
|
Vignola Mark J.
CFO |
Buy | 9,997 @ $1.41 | $14,096 | 17,656 | 05/31/2023 | 06/02/2023 | |
|
Yoon Seokho Bryan
COO and General Counsel |
Buy | 9,997 @ $1.41 | $14,096 | 17,656 | 05/31/2023 | 06/02/2023 | |
| Buy | 2,111 @ $1.41 | $2,977 | 9,770 | 05/31/2023 | 06/02/2023 | ||
|
ORBIMED ADVISORS LLC
Director |
Buy | 137,931 @ $7.25 | $1.00 M | 4,882,854 | 12/23/2022 | 12/28/2022 | |
|
GORDON CARL L
Director |
Buy | 137,931 @ $7.25 | $1.00 M | 4,882,854 | 12/23/2022 | 12/28/2022 | |
|
Vivo Opportunity, LLC
Director |
Buy | 758,620 @ $7.25 | $5.50 M | 4,340,212 | 12/23/2022 | 12/23/2022 | |
|
Lu Hongbo
Director |
Buy | 758,620 @ $7.25 | $5.50 M | 4,340,212 | 12/23/2022 | 12/23/2022 |
Terns Pharmaceuticals, Inc. Frequently Asked Questions
-
Who is on Terns Pharmaceuticals, Inc.'s Insider Roster?
The list of insiders at Terns Pharmaceuticals, Inc. includes Vignola Mark J., Yoon Seokho Bryan, Vivo Opportunity, LLC, Quigley Jill M., ORBIMED ADVISORS LLC, GORDON CARL L, Lu Hongbo.
-
How much insider selling is happening at Terns Pharmaceuticals, Inc.?
Insiders have sold a total of 589,991 Terns Pharmaceuticals, Inc. shares in the last 12 months for a total of 4.46 M sold.
-
Which Terns Pharmaceuticals, Inc. insiders have been selling company stock?
The following insiders have sold Terns Pharmaceuticals, Inc. shares in the last 12 months: Vivo Opportunity, LLC ($2.80 M), Quigley Jill M. ($433,590), ORBIMED ADVISORS LLC ($561,640), GORDON CARL L ($561,640), Vignola Mark J. ($110,000),
-
How much insider buying is happening at Terns Pharmaceuticals, Inc.?
Insiders have purchased a total of 487,258 Terns Pharmaceuticals, Inc. shares in the last 12 months for a total of 5.05 M sold.
-
Which Terns Pharmaceuticals, Inc. insiders have been buying company stock?
The following insiders have purchased Terns Pharmaceuticals, Inc. shares in the last 12 months: Vignola Mark J. ($24,081), Yoon Seokho Bryan ($24,081), Lu Hongbo ($5.00 M),